JHOP Articles

Skip to main content

Gastrointestinal Cancers

CheckMate 648 Study Data Indicate Improved Overall Survival for Patients with Advanced Esophageal Squamous-Cell Carcinoma Treated with Nivolumab and Ipilimumab or Chemotherapy

Gastrointestinal Cancers

Immune Checkpoint Analysis in Gastric Adenocarcinoma

Gastrointestinal Cancers

Second-Line Trastuzumab Deruxtecan in Patients with Metastatic Gastric or Esophageal Junction Cancer Demonstrates Clinical Efficacy

FDA Updates

Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer

FDA Updates

Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

FDA Updates

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

FDA Updates

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-Versus-Host Disease

FDA Updates

Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease

FDA Updates

Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer

FDA Updates

Brukinsa Approved for Marginal-Zone Lymphoma and for Waldenström’s Macroglobulinemia

Page 82 of 196
Results 811 - 820 of 1953